Genetics

1-9 of 9

• 

  RestartResume

  Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life

  CME/CE

  Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life

  • 

    

    Marc A. Riedl, MD, MS

    Peer

  1.00 credits

• 

  RestartResume

  Treatment of a Broader Population of Patients With DMD

  CME/CE

  Treatment of a Broader Population of Patients With DMD

  • 

    

    Crystal Proud, MD

    Peer

  • 

    

    Erika Finanger, MD, MS

    Peer

  1.00 credits

• 

  RestartResume

  New Frontiers in the Treatment of DMD Across the Age Spectrum

  CME/CE

  New Frontiers in the Treatment of DMD Across the Age Spectrum

  • 

    

    Crystal Proud, MD

    Peer

  • 

    

    John Brandsema, MD

    Peer

  • 

    

    Omer Abdul Hamid, MD

    Peer

  1.00 credits

• 

  MinuteCE®

  The Future of ADH1 - Looking at Emergent Treatments

  • 

    

    Michael A. Levine, MD, FAAP, MACE, FACP

    Peer

  • 

    

    B. Michelle Schweiger, DO, MPH

    Peer

  1.00 credits 4 episodes

• 

  RestartResume

  Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism

  MinuteCE®

  Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism

  • 

    

    Michael A. Levine, MD, FAAP, MACE, FACP

    Peer

  • 

    

    B. Michelle Schweiger, DO, MPH

    Peer

  1.00 program credits

• 

  RestartResume

  CASR and ADH1: Integrating Biology and Genetic Screening 

  MinuteCE®

  CASR and ADH1: Integrating Biology and Genetic Screening 

  • 

    

    Michael A. Levine, MD, FAAP, MACE, FACP

    Peer

  • 

    

    B. Michelle Schweiger, DO, MPH

    Peer

  1.00 program credits
• advertisement

• 

  RestartResume

  Therapeutic Options for ADH1 and Hypoparathyroidism

  MinuteCE®

  Therapeutic Options for ADH1 and Hypoparathyroidism

  • 

    

    Michael A. Levine, MD, FAAP, MACE, FACP

    Peer

  • 

    

    B. Michelle Schweiger, DO, MPH

    Peer

  1.00 program credits

• 

  RestartResume

  Emerging Therapeutics in ADH1: Progress in Precision Medicine

  MinuteCE®

  Emerging Therapeutics in ADH1: Progress in Precision Medicine

  • 

    

    Michael A. Levine, MD, FAAP, MACE, FACP

    Peer

  • 

    

    B. Michelle Schweiger, DO, MPH

    Peer

  1.00 program credits

• 

  RestartResume

  Case Management Strategies for Patients with ADPKD – Part 2

  CME/CE

  Case Management Strategies for Patients with ADPKD – Part 2

  • 

    

    Frederic Rahbari-Oskoui, MD, MSc

    Peer